TRNS | TranscatNASDAQTechnologyCommon stock golden cross and death cross projections, cross tests and history

$89.52
+$1.60 (+1.82%)

Transcat (TRNS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat above the 200 on the daily since Mar 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $89.52 vs 50 $86.10 / 200 $81.91
Projection
No cross projected
Test
No active test
Last cross
Golden cross 30 Mar 2026 ยท projected 30 bars out ยท tested 4 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $86.31 vs 50 $77.47 / 200 $91.26
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 1 Sep 2025 ยท projected 22 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $89.52 vs 50 $86.26 / 200 $88.18
Projection
Golden cross estimated in 20 to 28 bars
Test
No active test
Last cross
Death cross 25 Sep 2026 bar 1 ยท projected 28 bars out ยท tested 5 bars

Cross history

26
crosses on record since 2019
12 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
25 Sep 2026Death4-hour28 bars out5 bar cross test
30 Mar 2026Golden moderatedaily30 bars out4 bar cross test
9 Feb 2026Golden4-hour10 bars outNot tested
week of 1 Sep 2025Death moderateweekly22 bars outNot tested
14 Aug 2025Death4-hour22 bars outโ€”

About TRNS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorTechnology
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.